Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Mycronic AB ( (SE:MYCR) ) is now available.
Mycronic has received a replacement order from an existing Asian customer for a Prexision 8 Evo mask writer, a system designed to handle complex display photomask patterns, with an order value estimated between USD 14 million and USD 16 million and delivery scheduled for the first quarter of 2027. The deal highlights the strength of Mycronic’s trade-in program in helping customers modernize their installed base, underscoring the company’s entrenched role in the display industry’s high-end photomask segment and supporting ongoing demand for its pattern generator technology in a key Asian market.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK232.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
More about Mycronic AB
Mycronic is a Swedish high-tech company that develops, manufactures and markets high-precision, flexible production equipment for the electronics industry, including mask writers and metrology systems used in display manufacturing and semiconductor production. Headquartered in Täby outside Stockholm, the company operates through subsidiaries across Europe, Asia and the Americas, and its shares are listed on Nasdaq Stockholm.
Average Trading Volume: 230,238
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK41.91B
For a thorough assessment of MYCR stock, go to TipRanks’ Stock Analysis page.